Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer

scientific article published on 01 February 2019

Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1158/2326-6066.CIR-18-0686
P932PMC publication ID6685528
P698PubMed publication ID30709841

P50authorSteven RosenbergQ2347448
Yong-Chen LuQ42199992
P2093author name stringSatyajit Ray
Paul F Robbins
Li Jia
David S Schrump
Jared J Gartner
Anna Pasetto
Thomas E Shelton
Eric Tran
Biman C Paria
Parisa Malekzadeh
Maria Parkhurst
Isaac Kriley
Winifred Lo
Todd Prickett
Scott Kivitz
Drew Deniger
P2860cites workThe cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics dataQ28266682
Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortalQ28288215
P433issue4
P921main subjectcolorectal cancerQ188874
metastatic colon cancerQ108566365
P304page(s)534-543
P577publication date2019-02-01
P1433published inCancer Immunology ResearchQ26841983
P1476titleImmunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer
P478volume7

Reverse relations

cites work (P2860)
Q90479566Adoptive Cell Therapy Targeting Neoantigens: A Frontier for Cancer Research
Q90398709Adoptive Cell Therapy-Harnessing Antigen-Specific T Cells to Target Solid Tumours
Q99712014Key Players in the Mutant p53 Team: Small Molecules, Gene Editing, Immunotherapy
Q89965697Neoantigens in Hematologic Malignancies
Q96229731Structural basis for oligoclonal T cell recognition of a shared p53 cancer neoantigen
Q92245345T cell receptor-based cancer immunotherapy: Emerging efficacy and pathways of resistance
Q90176790T-Cell Immunotherapies Targeting Histocompatibility and Tumor Antigens in Hematological Malignancies
Q93157712Tumor neoantigens: from basic research to clinical applications

Search more.